Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

Conditions: Breast Cancer; Bladder Cancer; Kidney Cancer; Colon Cancer; Prostate Cancer; Lung Cancer; Ovarian Cancer
Interventions: Genetic: PCR/PCR/LDR Strategy
Sponsors: Memorial Sloan Kettering Cancer Center; Columbia University; Weill Medical College of Cornell University; Icahn School of Medicine at Mount Sinai
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 8, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments